SecBot SecBot

SLN

Silence Therapeutics plc
Nasdaq· Pharmaceutical Preparations· Inc. X0· CIK 0001479615 Biotech & Drug Discovery
$19.80 −0.03 (−0.15%)
Nov 16 4:00 PM ET · prev $19.83
Market cap
$1.2B
Small cap
Median target
$20.00
+1% · range $19.00–20.00
1 year
+195.5%
from $6.70 · Nov 17
30 days
+1.1%
from $19.58
52-week range
$4.30–19.83
−0% from high · low Feb 4
Avg volume 20D
2.13M
Oct 20 spike 13.96M
Short interest
2.42M
≈3.9% of shares · −17.4%
Days to cover
1.0
at average volume
Insider net
$0.00
0 buyers · 1 seller · 12 mo
New fund stakes
1
Q3 2026 13F · 0 exits
Filing reports
15
analyzed by SecBot
SecBot read BULLISH 10 reports · 90 days
Balance 0 bearish · 3 bullish · 7 neutral oldest → newest, height = score
Avg score ·High conf. 9/10

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersMIXED

    No open-market sales.

  • InstitutionsBULLISH

    Q3 2026: 20 added (1 new), 3 trimmed or exited. Largest new: Fmr $51.5M.

  • Short sellersCOVERING

    Short interest −17.4% to 2.42M shares. 1.0 days to cover, ≈3.9% of shares.

  • TrendUPTREND

    34% above its 50-day average. New closing high $19.83 on Nov 13.

Who's buying

13F· Q3 2026
1
new positions
0
exits
$51.5M
in new stakes
FundMoveSharesValue
FMR LLCNEW4,710,812$51.5M
MORGAN STANLEYDOUBLED1,761,030$19.2M
BNP PARIBAS FINANCIAL MARKETSDOUBLED1,173,108$12.8M
Qube Research & Technologies LtdDOUBLED1,058,988$11.6M
UBS Group AGDOUBLED609,678$6.7M
BlackRock, Inc.ADD330,529$3.6M
BARCLAYS PLCDOUBLED195,958$2.1M
JANE STREET GROUP, LLCTRIM192,595$2.1M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Oct 2026
12-month targets · 4 analysts

Price is inside the target range. Median implies +1%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Oct 21, 2026HC Wainwright & Co.
DOWNGRADE
DOWNGRADENeutral
Aug 11, 2026Morgan Stanley
MAINTAIN
MAINTAINOverweight
Jun 24, 2026Cantor Fitzgerald
INITIATE
INITIATEOverweight
Jun 17, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$0
sold · 1 insider
DateInsiderTypeValue
Aug 10, 2026
Griffiths Richard Ian
10%+ Owner
Aug 10, 2026
SELL605,174 sh
Aug 10, 2026
Griffiths Richard Ian
10%+ Owner
Aug 10, 2026
SELL100,000 sh
Aug 10, 2026
Griffiths Richard Ian
10%+ Owner
Aug 10, 2026
SELL60,000 sh
Aug 10, 2026
Griffiths Richard Ian
10%+ Owner
Aug 10, 2026
SELL50,000 sh
Aug 10, 2026
Griffiths Richard Ian
10%+ Owner
Aug 10, 2026
SELL2,792,826 sh
Aug 10, 2026
Griffiths Richard Ian
10%+ Owner
Aug 10, 2026
SELL120,000 sh
Aug 10, 2026
Griffiths Richard Ian
10%+ Owner
Aug 10, 2026
SELL382,000 sh
Aug 10, 2026
Griffiths Richard Ian
10%+ Owner
Aug 10, 2026
SELL470,820 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
2,418,248
shares short
-17.4%
vs prior settlement
1.0
days to cover
≈3.9%
of shares outstanding
Trading halts
Oct 19, 2026Resumption ScheduledResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 12, 2026 SEC
Invus Global Management and affiliated entities filed an amended Schedule 13G disclosing a 4.6% aggregate beneficial…
SC 13G/A · Impact 3/10
Nov 12, 2026 SEC
Silence Therapeutics reported Q3 2026 results showing a reduced net loss of $12.4M ($0.08/share) versus $21.0M…
DEFA14A · Impact 4/10
Oct 19, 2026 Trading halt
Halt Resumed: SLN, trading resumed after T3 (News and Resumption Times)
Halted 2026-10-19T11:55:00.000Z | Resumed 2026-10-19T12:20:00.000Z
Sep 30, 2026 Inst.
FMR LLC · NEW
4,710,812 shares ($51.5M)
Sep 30, 2026 Inst.
MORGAN STANLEY · DOUBLED
1,761,030 shares ($19.2M)
Aug 10, 2026 Insider
Griffiths Richard Ian sold 605,174 shares
10%+ Owner
Aug 10, 2026 Insider
Griffiths Richard Ian sold 100,000 shares
10%+ Owner
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

15 filings · 4 bullish · 1 bearish · 1 mixed · 9 neutral
All SLN filing & press-release reports (15)